Literature DB >> 5567266

Manic response to levodopa therapy. Report of a case.

R S Ryback, R S Schwab.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 5567266     DOI： 10.1056/NEJM197109302851409

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  8 in total

Review 1.  Review of clinically important drug interactions with lithium.

Authors:  N S Harvey; S Merriman
Journal:  Drug Saf       Date:  1994-06       Impact factor: 5.606

2.  REM ocular activity in Parkinsonian patients chronically treated with levodopa.

Authors:  P Lavie; E Bental; H Goshen; B Sharf
Journal:  J Neural Transm       Date:  1980       Impact factor: 3.575

Review 3.  Assessment and treatment of bipolar disorder in the elderly.

Authors:  J H Eastham; D V Jeste; R C Young
Journal:  Drugs Aging       Date:  1998-03       Impact factor: 3.923

Review 4.  Drug-induced mania.

Authors:  M Peet; S Peters
Journal:  Drug Saf       Date:  1995-02       Impact factor: 5.606

Review 5.  Psychological effects caused by drugs in overdose.

Authors:  L Evans
Journal:  Drugs       Date:  1980-03       Impact factor: 9.546

Review 6.  Drug-induced mania in the elderly.

Authors:  L Ganzini; S B Millar; J R Walsh
Journal:  Drugs Aging       Date:  1993 Sep-Oct       Impact factor: 3.923

Review 7.  Drug-induced mania--causative agents, clinical characteristics and management. A retrospective analysis of the literature.

Authors:  D L Sultzer; J L Cummings
Journal:  Med Toxicol Adverse Drug Exp       Date:  1989 Mar-Apr

8.  Preexisting Bipolar Disorder Influences the Subsequent Phenotype of Parkinson's Disease.

Authors:  Marco Onofrj; Angelo Di Iorio; Claudia Carrarini; Mirella Russo; Raffaella Franciotti; Alberto J Espay; Laura S Boylan; John-Paul Taylor; Massimo Di Giannantonio; Giovanni Martinotti; Enza M Valente; Astrid Thomas; Laura Bonanni; Stefano Delli Pizzi; Fedele Dono; StefanoL Sensi
Journal:  Mov Disord       Date:  2021-08-24       Impact factor: 9.698
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.